Tim Demuth's Insider Trades & SAST Disclosures

Tim Demuth's most recent trade in Pieris Pharmaceuticals Inc was a trade of 6,000 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 13, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pieris Pharmaceuticals Inc
Tim Demuth Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.71 per share. 13 May 2022 6,000 6,000 (0%) 0% 1.7 10,260 Common Stock
Pieris Pharmaceuticals Inc
Tim Demuth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 100,000 100,000 - - Stock Option (Right to buy)
Pieris Pharmaceuticals Inc
Tim Demuth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2021 360,000 360,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades